ArticleFrontiers in endocrinology2018

The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 Inhibition.

Yu Seol Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.